# Senicapoc and Dehydrated Stomatocytosis

> **NCT04372498** · PHASE1,PHASE2 · COMPLETED · sponsor: **Boston Children's Hospital** · enrollment: 5 (actual)

## Conditions studied

- Dehydrated Hereditary Stomatocytosis

## Interventions

- **DRUG:** Senicapoc (synonyms: ICA-17043; 2,2-bis-(4-fluorophenyl)-2-phenylacetamide)

## Key facts

- **NCT ID:** NCT04372498
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-15
- **Primary completion:** 2024-02-01
- **Final completion:** 2024-02-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04372498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04372498, "Senicapoc and Dehydrated Stomatocytosis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04372498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*